Financials

News Ideas Technicals

300966 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to HUBEI GOTO BIOPHAR operating, investing, and financing activities

300966 free cash flow for Q1 24 is -82.45 M CNY. For 2022, 300966 free cash flow was -431.98 M CNY and operating cash flow was -24.04 M CNY.

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q1 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: CNY

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q1 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—